2-Naphthaleneboronic acid | CAS:32316-92-0

We serve 2-Naphthaleneboronic acid CAS:32316-92-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Naphthaleneboronic acid

Product Name: 2-Naphthaleneboronic acid
Other Name:
2-Naphthaleneboronic acid
naphthalen-2-ylboronic acid
2-naphthaleneylboronic acid
2-Naphthylboronic Acid
naphthalene-2-boronic acid
Naphthalenyl-2-boronic acid
Naphthalen-2-Yl-Boranediol
2-Naphthyl-phenylboronic acid
CAS No: 32316-92-0
MF: C10H9BO2
MW: 171.98800
Density: 1.21g/cm3
Boiling point: 381.9ºC at 760 mmHg
Melting point: 269-275 °C(lit.)
Flash point: NA
Refractive index: 1.638
UN Number: UN2924
Transport hazard class: 3
Packing group: II
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2-Naphthaleneboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Naphthyl-phenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Naphthalen-2-Yl-Boranediol Use and application,Naphthalen-2-Yl-Boranediol technical grade,usp/ep/jp grade.


Related News: Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.1,2,3,9-TETRAHYDRO-4H-9-METHYL-CARBAZOLE-4-ONE manufacturer Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.2-Bromobutyric acid methyl ester supplier Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.5-Bromo-3-nitro-2-pyridinol vendor This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs.Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.